AnPac Bio-Medical Science Announces Closing of $3.0 Million Registered Direct OfferingPRNewsWire • 04/06/23
AnPac Bio-Medical Science Enters into Asset Purchase Agreement with Easy Hundred Inc.PRNewsWire • 04/03/23
AnPac Bio-Medical Science Announces Pricing of $3.0 Million Registered Direct OfferingGlobeNewsWire • 04/01/23
AnPac Bio-Medical Science Granted Continued Listing by NASDAQ Hearing Panel, Subject to Meeting the Equity Rule on or before July 12, 2023PRNewsWire • 03/23/23
AnPac Bio Announces Receipt of the First Payment from a Malaysia Customer On a Signed US$1.5 Million Cancer Detection Equipment Purchase ContractPRNewsWire • 03/07/23
AnPac Bio Announces Positive Results from its Multi-Year and Multi-Cancer Test Follow-Up StudyPRNewsWire • 02/22/23
AnPac Bio-Medical Science Acquires GISN (HK) LIMITED, a Technical Solution and Outsourcing Consulting Services ProviderPRNewsWire • 02/15/23
AnPac Bio-Medical Science Enters into Definitive Agreement to Make Another Acquisition to Significantly Expand Scope of Business in the U.S.PRNewsWire • 02/13/23
AnPac Bio-Medical Science Enters into Definitive Agreement to Acquire Fresh2 Ecommerce Inc, a B2B Asian Food E-commerce PlatformPRNewsWire • 02/09/23
AnPac Bio-Medical Science Announces Signing of US$5.2 Million of Definitive Investment AgreementsGlobeNewsWire • 01/25/23
AnPac Bio-Medical Sciences Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request A HearingGlobeNewsWire • 01/20/23
AnPac Announces Strategic Initiative to Establish A Wholly-Owned Subsidiary for US Food MarketGlobeNewsWire • 12/05/22
AnPac Bio Granted Continued Listing by NASDAQ Hearing Panel, Subject to Meeting $1 Bid Price Compliance Rule On or Before Nov. 23, 2022GlobeNewsWire • 11/04/22